Vegard Bruun Wyller (f. 1972) er spesialist i barnesykdommer og professor ved Institutt for klinisk medisin, Universitetet i Oslo, overlege ved Barne- og ungdomsklinikken, Akershus universitetssykehus og medisinsk redaktør i Tidsskriftet.
Forfatteren har fylt ut ICMJE-skjemaet og oppgir ingen interessekonflikter.
Tom Eirik Mollnes (f. 1956) er spesialist i immunologi og transfusjonsmedisin, forsker ved Nordlandssykehuset, Bodø, og professor II ved Universitetet i Tromsø, Universitetet i Oslo, og ved Senter for molekylær inflammasjonsforskning (SFF-CEMIR) ved Norges teknisk-naturvitenskapelige universitet.
Forfatteren har fylt ut ICMJE-skjemaet og oppgir ingen interessekonflikter.
()
1.
Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: Redefining an illness. Washington, D.C.: The National Academies Press, 2015.
2.
Albright F, Light K, Light A et al. Evidence for a heritable predisposition to Chronic Fatigue Syndrome. BMC Neurol 2011; 11: 62. [PubMed] [CrossRef]
3.
Sirois FM, Molnar DS. Perfectionism and maladaptive coping styles in patients with chronic fatigue syndrome, irritable bowel syndrome and fibromyalgia/arthritis and in healthy controls. Psychother Psychosom 2014; 83: 384 – 5. [PubMed]
4.
Hickie I, Davenport T, Wakefield D et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006; 333: 575 – 81. [PubMed] [CrossRef]
5.
Theorell T, Blomkvist V, Lindh G et al. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999; 61: 304 – 10. [PubMed] [CrossRef]
6.
Sulheim D, Fagermoen E, Sivertsen ØS et al. Cognitive dysfunction in adolescents with chronic fatigue: a cross-sectional study. Arch Dis Child 2015; 100: 838 – 44. [PubMed] [CrossRef]
7.
Wyller VB, Barbieri R, Thaulow E et al. Enhanced vagal withdrawal during mild orthostatic stress in adolescents with chronic fatigue. Ann Noninvasive Electrocardiol 2008; 13: 67 – 73. [PubMed] [CrossRef]
8.
Wyller VB, Due R, Saul JP et al. Usefulness of an abnormal cardiovascular response during low-grade head-up tilt-test for discriminating adolescents with chronic fatigue from healthy controls. Am J Cardiol 2007; 99: 997 – 1001. [PubMed] [CrossRef]
Bansal AS, Bradley AS, Bishop KN et al. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun 2012; 26: 24 – 31. [PubMed] [CrossRef]
11.
Blundell S, Ray KK, Buckland M et al. Chronic fatigue syndrome and circulating cytokines: A systematic review. Brain Behav Immun 2015; 50: 186 – 95. [PubMed] [CrossRef]
12.
Wyller VB, Sørensen Ø, Sulheim D et al. Plasma cytokine expression in adolescent chronic fatigue syndrome. Brain Behav Immun 2015; 46: 80 – 6. [PubMed] [CrossRef]
13.
Wyller VB, Eriksen HR, Malterud K. Can sustained arousal explain the Chronic Fatigue Syndrome? Behav Brain Funct 2009; 5: 10. [PubMed] [CrossRef]
14.
Maloney EM, Boneva R, Nater UM et al. Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia. Psychosom Med 2009; 71: 549 – 56. [PubMed] [CrossRef]
15.
Nijs J, Meeus M, Van Oosterwijck J et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest 2012; 42: 203 – 12. [PubMed] [CrossRef]
16.
Boksem MAS, Tops M. Mental fatigue: costs and benefits. Brain Res Brain Res Rev 2008; 59: 125 – 39. [PubMed] [CrossRef]
17.
Verguts T, Vassena E, Silvetti M. Adaptive effort investment in cognitive and physical tasks: a neurocomputational model. Front Behav Neurosci 2015; 9: 57. [PubMed] [CrossRef]
18.
Poon DC, Ho YS, Chiu K et al. Cytokines: how important are they in mediating sickness? Neurosci Biobehav Rev 2013; 37: 1 – 10. [PubMed] [CrossRef]
19.
Overmier JB. Sensitization, conditioning, and learning: can they help us understand somatization and disability? Scand J Psychol 2002; 43: 105 – 12. [PubMed] [CrossRef]
20.
Cameron B, Bharadwaj M, Burrows J et al. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. J Infect Dis 2006; 193: 664 – 71. [PubMed] [CrossRef]
21.
Arnsten AFT, Li B-M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 2005; 57: 1377 – 84. [PubMed] [CrossRef]
22.
Lucini D, Di Fede G, Parati G et al. Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension 2005; 46: 1201 – 6. [PubMed] [CrossRef]
23.
Yehuda R, Giller EL, Southwick SM et al. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry 1991; 30: 1031 – 48. [PubMed] [CrossRef]
24.
Rohleder N. Acute and chronic stress induced changes in sensitivity of peripheral inflammatory pathways to the signals of multiple stress systems – 2011 Curt Richter Award Winner. Psychoneuroendocrinology 2012; 37: 307 – 16. [PubMed] [CrossRef]
25.
Sanders VM. The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? Brain Behav Immun 2012; 26: 195 – 200. [PubMed] [CrossRef]
26.
Bower JE, Ganz PA, Irwin MR et al. Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun 2011; 25: 147 – 50. [PubMed] [CrossRef]
27.
Sulheim D, Fagermoen E, Winger A et al. Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial. JAMA Pediatr 2014; 168: 351 – 60. [PubMed] [CrossRef]
28.
Fukuda K, Straus SE, Hickie I et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953 – 9. [PubMed] [CrossRef]
29.
Nisenbaum R, Reyes M, Unger ER et al. Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? J Psychosom Res 2004; 56: 171 – 8. [PubMed] [CrossRef]
30.
Sullivan PF, Pedersen NL, Jacks A et al. Chronic fatigue in a population sample: definitions and heterogeneity. Psychol Med 2005; 35: 1337 – 48. [PubMed] [CrossRef]
31.
Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children. NICE clinical guideline 53. London: National Institute for Health and Clinical Excellence, 2007.
32.
Carruthers BM, Jain AK, De Meirleir KL et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: clinical working case definition, diagnostic and treatment Protocols. J Chronic Fatigue Syndr 2003; 11: 7 – 11. [CrossRef]
33.
Carruthers BM, van de Sande MI, De Meirleir KL et al. Myalgic encephalomyelitis: International consensus criteria. J Intern Med 2011; 270: 327 – 38. [PubMed] [CrossRef]
34.
Brurberg KG, Fønhus MS, Larun L et al. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. BMJ Open 2014; 4: e003973. [PubMed] [CrossRef]
35.
Asprusten TT, Fagermoen E, Sulheim D et al. Study findings challenge the content validity of the Canadian Consensus Criteria for adolescent chronic fatigue syndrome. Acta Paediatr 2015; 104: 498 – 503. [PubMed] [CrossRef]
36.
Wyller VB, Bjørneklett A, Brubakk O et al. Diagnostisering og behandling av kronisk utmattelsessyndrom/myalgisk encefalopati (CFS/ME). Rapport nr. 9/2006. Oslo: Kunnskapssenteret, 2006.
37.
Wiborg JF, van Bussel J, van Dijk A et al. Randomised controlled trial of cognitive behaviour therapy delivered in groups of patients with chronic fatigue syndrome. Psychother Psychosom 2015; 84: 368 – 76. [PubMed] [CrossRef]
38.
Smith ME, Haney E, McDonagh M et al. Treatment for myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review for a National Institutes of Health Pathways to Prevention workshop. Ann Intern Med 2015; 162: 841 – 50. [PubMed] [CrossRef]
39.
Nijhof SL, Bleijenberg G, Uiterwaal CS et al. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet 2012; 379: 1412 – 8. [PubMed] [CrossRef]
40.
White PD, Goldsmith KA, Johnson AL et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011; 377: 823 – 36. [PubMed] [CrossRef]
Dougall D, Johnson A, Goldsmith K et al. Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome. J Psychosom Res 2014; 77: 20 – 6. [PubMed] [CrossRef]
43.
Fluge Ø, Bruland O, Risa K et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS ONE 2011; 6: e26358. [PubMed] [CrossRef]
44.
Rashidi A, Oak E, Bartlett NL. Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma. Blood 2015; 125: 3354 – 5. [PubMed] [CrossRef]
45.
Grainger M, Dilley C, Wood N et al. Osteoporosis among young adults with complex physical disabilities. Br J Nurs 2011; 20: 171 – 5. [PubMed] [CrossRef]
46.
Mason OJ, Brady F. The psychotomimetic effects of short-term sensory deprivation. J Nerv Ment Dis 2009; 197: 783 – 5. [PubMed] [CrossRef]
Angelsen A, Egeland T, Haug R, et al. De ME-syke fortjener seriøs forskning! Aftenposten 3.12.2014.
49.
Holgate ST, Komaroff AL, Mangan D et al. Chronic fatigue syndrome: understanding a complex illness. Nat Rev Neurosci 2011; 12: 539 – 44. [PubMed] [CrossRef]
50.
Beauregard M. Mind does really matter: evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect. Prog Neurobiol 2007; 81: 218 – 36. [PubMed] [CrossRef]
51.
Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA 2011; 306: 277 – 86. [PubMed]
52.
Passos IC, Vasconcelos-Moreno MP, Costa LG et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2015; 2: 1002 – 12. [PubMed] [CrossRef]
53.
Segerstrøm SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004; 130: 601 – 30. [PubMed] [CrossRef]
54.
Nakatomi Y, Mizuno K, Ishii A et al. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study. J Nucl Med 2014; 55: 945 – 50. [PubMed] [CrossRef]
55.
Hinwood M, Morandini J, Day TA et al. Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex 2012; 22: 1442 – 54. [PubMed] [CrossRef]
56.
Grutle IF. Alt om ME-gjennombruddet. TV2 20.10.2011.
Fra to artikler i Tidsskriftet (1,2) kan det virke som om de vitenskapelige kontroversene rundt kronisk utmattelsessyndrom/myalgisk encefalopati (CFS/ME) skyldes mangelfulle kriteriesett og utilstrekkelige data. Men dette er bare delvis riktig, og da…
Retorisk utmattelsessyndrom. Det er synd at debatten om kronisk utmattelsessyndrom/myalgisk encefalopati er så betent at en kronikk om sykdomsmekanismer, diagnostikk og behandling munner ut i en høystemt hyllest av sannheten som man tilsynelatende selv mener å…
Takk til Wyller og medarbeidere for en klargjørende artikkel om et brennbart tema, CFS/ME (1). Det burde berolige både kritikere av denne forståelsen og pasientene, at det ikke påstås at CFS/ME skyldes psykisk lidelse. Jeg har fulgt disse pasientene ganske…
Bruun Wyller og medarbeidere oppsummerer i Tidsskriftet sin forståelse av myalgisk encefalopati (ME) som en vedvarende stressrespons (1). Kronikken må forstås som en kommentar til Egeland og medarbeidere om ME hvor vi oppsummerer internasjonal status for…
Mottatt 4.11. 2015, første revisjon innsendt 16.11. 2015, godkjent 18.11. 2015. En av forfatterne er redaktør i Tidsskriftet. Manuskriptet er derfor behandlet eksternt av setteredaktør Pål Gulbrandsen.
Mottatt 4.11. 2015, første revisjon innsendt 16.11. 2015, godkjent 18.11. 2015. En av forfatterne er redaktør i Tidsskriftet. Manuskriptet er derfor behandlet eksternt av setteredaktør Pål Gulbrandsen.
Får du ikke vist PDF-filen eller vil lagre filen, kan du høyreklikke på PDF-ikonet. Velg «Lagre mål/fil som..» og hent så opp PDF-filen i for eksempel Acrobat Reader.
RE: Kronisk utmattelsessyndrom/myalgisk encefalopati - sykdo
07.12.2015Fra to artikler i Tidsskriftet (1,2) kan det virke som om de vitenskapelige kontroversene rundt kronisk utmattelsessyndrom/myalgisk encefalopati (CFS/ME) skyldes mangelfulle kriteriesett og utilstrekkelige data. Men dette er bare delvis riktig, og da…